Sera Prognostics

Q2 FY2026 EarningsQ2 FY2026 results missed consensus on the top and bottom lines, with revenue of $30K vs. $50K expected and a GAAP EPS loss of $0.18 vs. $0.155 expected. Despite a 76% YoY revenue increase, the company remains in the early stages of commercialization, with operating expenses rising to $10.0M due to higher commercial and marketing investments. A key positive is the enactment of the Illinois Medicaid coverage mandate, potentially addressing 50,000 annual births, and a solid cash position of $80.3M to fund operations through 2029.